Watson Pharmaceuticals, Inc. today confirmed that the U.S. Court of Appeals for the Federal Circuit Court has affirmed a March 31, 2009 District Court decision that the asserted claims of ALZA's United States Patent No. 6,919,373 "the '373 Patent" are invalid.
The details can be read here.
Tuesday, April 27, 2010
Shire Receives INTUNIV Paragraph IV Notice Letter From Anchen
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter from Anchen Pharmaceuticals, Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of Shire's 1 mg, 2 mg, 3 mg, and 4 mg guanfacine hydrochloride extended release tablets, INTUNIV(TM).
The details can be read here.
The details can be read here.
Actavis Launches Generic Version of Flomax In The U.S.
Actavis Inc., today began shipping Tamsulosin capsules to its customers in the United States. The generic equivalent to Flomax®, Tamsulosin is used to treat benign prostatic hyperplasia (BPH).
The details can be read here.
The details can be read here.
Monday, April 26, 2010
Heartburn for Sun Pharma and Teva in the US
Mumbai: Sun Pharmaceuticals and Teva received a blow after a US federal jury ruled that Pfizer Inc and Altana AG have valid patents for acidity medicine Protonix (pantoprazole).
The details can be read here.
The details can be read here.
Subscribe to:
Posts (Atom)